All News

According to a new study by West Health and Gallup, 88% of US adults support the federal government directly negotiating the price of a COVID-19 treatment with a drug manufacturer upon its availability due to concerns regarding raised drug prices.

In the United States, 3.5 million people have been diagnosed with schizophrenia and it is a leading cause of disability.

What year was the second dose of the measles, mumps, and rubella (MMR) vaccine recommended?

Top news of the week from Pharmacy Times®.

The FDA has approved tazemetostat for the treatment of 2 different follicular lymphoma (FL) indications.

Guselkumab is a monoclonal antibody that selectively binds to the p19 subunit of IL-23 and inhibits its interaction with the IL-23.

Student pharmacists across the country have had to adjust their expectations of what P4 year will look like.

Experts discuss insights from NHA's 2019 Industry Outlook research from employers of pharmacy technicians to better understanding their needs and the value of certification for this role.

Today, we’re celebrating Morgan Adams, PharmD, a pharmacist with CVS in Connecticut.

Research shows that the over-prescribing of opioids for short term pain management is a widespread issue in the United States.

SE requires prompt intervention to terminate seizure activity to prevent neuronal damage and complications.

Antibodies isolatied from plasma donated from recovered COVID-19 patients fights the virus that causes COVID-19.

Statins have been and continue to be the first-choice therapy options for patients, but the addition of Nexletol adds a different new dimension to managing this disease.

Pharmacy managers will need to employ effective decision-making that will include evaluating vendors for post-purchase support, and discern the right time to purchase technology.

Giant Food has announced that all vaccinations recommended by the ACIP are once again available at its 153 in-store pharmacies across Virginia, Maryland, Delaware, and the District of Columbia.

individuals with four or more depressive symptoms had a 20% increase in cardiovascular events and death.

Galcanezumab-gnlm (Emgality, Lilly) has received FDA-approval for the preventive treatment of migraine in adults and for the treatment of episodic cluster headache in adults.

Pembrolizumab (Keytruda, Merck) monotherapy approved for adult and pediatric patients with unresectable or metastatic tumor mutational burden-high solid tumors.

Ertugliflozin is a relatively new addition to the SGLT2 inhibitor class of medication.

The most common adverse reactions observed in the monarchE phase 3 trial include diarrhea, neutropenia, fatigue, infections, nausea, abdominal pain, vomiting, anemia, alopecia, decreased appetite, and leukopenia.

Today, we’re celebrating Manzil Panchal, BS Pharm, owner and pharmacy manager at East Norriton Pharmacy in Pennsylvania.

The participants were categorized according to their vitamin K levels and heart disease. However, those with the lowest vitamin K levels had a 19% higher risk of death, compared with those whose vitamin K levels reflected adequate vitamin K intake.

Lurbinectedin (Zepzelca) approved based on overall response rate and duration of response in patients with metastatic small cell lung cancer with disease progression on or after platinum-based chemotherapy.

Owen Mumford’s Unifine® SafeControl® safety pen needle is designed to prevent accidental needlestick injuries and provides users with confidence that the whole dose was delivered.

This is an important area for pharmacists to apply their knowledge of medications.

Although many hubs offer similar services, no two specialty pharmacy hubs and no two hub programs are entirely alike.

In addition to adhering to the CDC recommendations, pharmacies should consider workflow changes intended to minimize risk to both patients and the pharmacy staff providing immunization services.

Today, we’re celebrating Farzana Qavi, RPh, who works at Massachusetts General Hospital in Boston.